This Article  • PDF of this Correction  • Original article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Psychiatry  • Depression  • Randomized Controlled Trial  • Alert me on articles by topic  Social Bookmarking   What's this?

JAMA. 2002;287:3083.

Incorrect Wording. There was incorrect wording in the Editorial entitled "Placebo in Clinical Trials for Depression: Complexity and Necessity" published in the April 10, 2002, issue of THE JOURNAL (2002;287:1853-1854). The last 3 sentences in the fourth paragraph should read as follows: From this 8-week clinical trial, the authors conclude that neither sertraline nor hypericum was significantly different from placebo on either of the primary outcome measures: change in total Hamilton Depression Scale (HAM-D) score and full response defined by combined cut-off scores on both the HAM-D and the Clinical Global Impression Scale (CGI-I). However, sertraline was significantly better than placebo (P = .02) on the CGI-I alone, which was a secondary outcome measure in this study. The overall response rates (including partial and full response) were 38.1% for hypericum, 43.1% for placebo, and 48.6% for sertraline.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?